SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics is trending after announcing a proposed non-binding business combination with Applied Digital's cloud computing division to form ChronoScale, an AI-focused GPU compute platform. This strategic pivot into the booming AI infrastructure sector has ignited fervent community discussion, with many anticipating significant upside and a short squeeze. Conversely, some investors are expressing caution regarding potential dilution and the existing shareholders' anticipated smaller stake in the new entity.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is trending due to a recently awarded eight-figure contract for spacecraft docking systems, fueling community discussions about its role in the rapidly expanding space infrastructure and defense sectors. Investors are actively debating its potential for a significant short squeeze, viewing it as an undervalued asset positioned for substantial growth in a market increasingly compared to the early stages of AI development.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending amidst intense speculation regarding a potential "black box warning" for mRNA COVID-19 vaccines, which proponents believe could significantly elevate its protein-based alternative. The community is also actively discussing a major partnership or acquisition for Novavax's combined flu/COVID vaccine and Matrix-M adjuvant, fueled by recent M&A activity in the sector and mounting pressure on current management from activist investor Shah Capital for decisive action.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is at the center of investor speculation ahead of an anticipated Department of Energy announcement on plutonium awards, a critical development for the small modular reactor sector powering future energy needs. The community is buzzing with bullish sentiment around this potential catalyst and strong technical indicators, while skeptics point to recent insider selling, share dilution, and the company's pre-revenue status as concerns impacting its valuation.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is highly active amid strong Phase 3 data for relacorilant in platinum-resistant ovarian cancer, touted by many as a potential new standard of care and multi-billion-dollar opportunity. This pivotal news, coupled with encouraging survival data for its ALS program and an upcoming FDA decision for Cushing Syndrome, has intensified community discussions around the stock's underlying value and the potential for a massive short squeeze.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is a focal point of discussion as investors anticipate potential breakthroughs at the upcoming CES 2026, with recent analyst upgrades fueling optimism for its voice AI solutions in the automotive and restaurant sectors. While many bulls highlight the company's debt-free status, rapid revenue growth, and substantial backlog, others express frustration over recent price drops and insider selling, questioning short-term trajectory amidst ongoing volatility. Community sentiment is divided between those expecting significant gains from its innovative agentic AI and potential profitability in 2026, and those wary of past volatility and the stock's struggle to maintain upward momentum.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending due to a Reuters report suggesting Nvidia halted testing of its 18A chip process, sparking debate on whether this is a legitimate setback or a "hit piece" to manipulate the stock. The community is highlighting Nvidia's recent $5 billion equity investment and Intel's critical role as the leading US-based advanced chip manufacturer, anticipating future catalysts like CES and foundry customer announcements to drive substantial growth.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing heightened volatility due to impending Chinese export restrictions on silver, set to take effect early next year, and strong industrial demand from sectors like EVs and AI. The community is deeply divided between those anticipating a historic supply squeeze and genuine price discovery, and others cautioning a speculative bubble fueled by recent market movements and past price suppression tactics.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is generating significant discussion as multiple near-term FDA decisions approach for its diverse pipeline, including a motion sickness treatment anticipated to potentially mitigate GLP-1 induced nausea. The community is keenly observing the improved regulatory dynamic with the FDA and evaluating the company's undervalued status given a strong balance sheet and several event-driven catalysts. Many traders are positioning for these binary events, drawing comparisons to other recent biotech stock movements.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind Corp is currently trending following the recent FDA approval of its FUROSCIX treatment for pediatric patients and the issuance of new patents for the ReadyFlow Autoinjector, signaling potential for expanded market access. The community is actively debating the commercial impact of these developments and keenly anticipating updates on the Afrezza launch in India, contributing to a largely positive analyst outlook for the company's growth trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ILLMF First Quarter Revenue of $29.1 Million up 17% YoY
Exchange Service Revenue up 148% YoY https://www.crweworld.com/article/news-provided-by-globenewswire/3643704/illumin-reports-first-quarter-2025-financial-results

Tony

Braggs2

Kyle

First Quarter Revenue of $29.1 Million up 17% YoYExchange Service Revenue up 148% YoY (All monetary figures are expressed in Canadian dollars unless otherwise stated) TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (

CRWE World

illumin Reports First Quarter 2025 Financial Results

StockTwits For Android 

AcuityAds Holdings Inc

 First Quarter Revenue of $29.1 Million up 17% YoY
Exchange Service Revenue up 148% YoY 